• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Ion Channel Modulators - Global Strategic Business Report

  • ID: 2531224
  • April 2015
  • Region: Global
  • 161 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2014 through 2018. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 47 companies including many key and niche players such as -

- AstraZeneca
- Bayer HealthCare
- CalciMedica, Inc.
- Convergence Pharmaceuticals Limited
- Evotec AG

Note: Product cover images may vary from those shown

ION CHANNEL MODULATORS

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Ion Channel Modulators
A Receding Market
Current and Future Analysis
Impending Patent Expiries of Select Ion Channel Modulators
Currently Available Ion Channel Modulating Drugs in the Market
Select Ion Channel Modulator Drugs by Mode of Action
Competitive Scenario
Table 1: Global Ion Channel Modulators Market by Top Ten Drugs (2013): Percentage Share Breakdown of Revenues (includes corresponding Graph/Chart)

2. ION CHANNEL MODULATORS BY THERAPEUTIC INDICATION
Cardiovascular Diseases/ Hypertension
Select Major Anti-Hypertensive Drugs Targeting Ion Channels: 2014
Table 2: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
Table 3: Fatalities by Heart Conditions
Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
Table 4: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart)
Table 5: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
Ion Channel Modulation in Arrhythmia Treatment
Select Anti-Arrhythmic Drugs Targeting Ion Channels: 2014
Ion Channel Modulation in Convulsions
Select Anti-Convulsant Drugs Targeting Ion Channels: 2014
Ion Channel Modulation in Pain Management
Pain Management/Analgesic Drugs Targeting Ion Channels: 2014
Ion Channel Modulation in Oncology
Ion Channel Modulation of Antidiabetic Agents
Ion Channel Modulation of Antiemetics
Ion Channel Modulators Find Extensive Use in Neglected Tropical Diseases
Ion Channel Modulation in Other Therapeutic Areas
Select Ion Channel Modulators for Other Therapeutic Indications: 2014

3. MARKET DYNAMICS
Aging Population: Sustaining the Market
Table 7: Global Population Worldwide: Percentage Share Breakdown by Age Group for the year 2025 (includes corresponding Graph/Chart)
Table 8: Global Population of People Aged 65+ Years (In Million) for the Years 2012, 2020 & 2050 (includes corresponding Graph/Chart)
Ion Channel Screening Aided by APC
Increased Interest Witnessed in Outsourcing of Ion Channel Services
Limitations and Challenges
Ion Channels
Difficult Drug Targets
The Threat Posed by the Influx of Generic Drugs

4. PRODUCT OVERVIEW
Ion Channel Modulators: An Introduction
Biological Significance of Ion Channels
Ion Channel Modulators as an Option for Treating Diseases
Types of Ion Channels
Voltage-Gated Ion Channels
Extracellular Ligand-gated Ion Channels
Intracellular Ligand-gated Ion Channels

5. RECENT INDUSTRY ACTIVITY
Pfizer Wins Court Ruling to Block Generic Versions of Lyrica Upto 2018
Forest Labs Discontinues Namenda 5/10 mg
Tablets, Launches Namenda XR
Forest Files Lawsuit against Namenda Generic Manufacturers
Cytocentrics Bioscience Selects Drug Safety Testing Center as its Distributor in Japanese Market
Zalicus Licenses Its Entire Sodium Channel Modulator Program to AnaBios Corporation
EPIRUS Merges with Zalicus
XENTION Collaborates with SERVIER for Kv1.5 Modulator Project
Aurora Biomed Inks Agreement with Specs and Alion Pharmaceuticals
Hydra and Zalicus Enter into Partnership
Hydra Biosciences and Cubist Pharmaceuticals to Commence Phase 1 Clinical Trial for TRPA1 Antagonist CB-625
Vertex Pharmaceuticals Receives USFDA Approval for KALYDECO™

6. FOCUS ON SELECT GLOBAL PLAYERS
AstraZeneca (UK)
Bayer HealthCare (Germany)
CalciMedica, Inc. (US)
Convergence Pharmaceuticals Limited (UK)
Evotec AG (Germany)
Forest Laboratories, LLC (US)
GlaxoSmithKline Plc. (UK)
Johnson & Johnson (US)
Lundbeck (Denmark)
Novartis AG (Switzerland)
Parion Sciences, Inc. (US)
Pfizer, Inc. (US)
Neusentis, Inc. (US)
Sanofi S.A. (France)
Targacept, Inc. (US)
Xention Limited (UK)

7. GLOBAL MARKET PERSPECTIVE
Table 9: World Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 10: World Historic Review for Ion Channel Modulators by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 11: World 12-Year Perspective for Ion Channel Modulators by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Overview
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 12: The US Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 13: The US Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Strategic Corporate Development
B.Market Analytics
Table 14: Canadian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 15: Canadian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Strategic Corporate Development
B.Market Analytics
Table 16: Japanese Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 17: Japanese Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Overview
B.Market Analytics
Table 18: European Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 19: European Historic Review for Ion Channel Modulators by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 20: European 12-Year Perspective for Ion Channel Modulators by Geographic Region
Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2018 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Sanofi S.A.
A Key Player
B.Market Analytics
Table 21: French Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 22: French Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Key Players
B.Market Analytics
Table 23: German Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 24: German Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 25: Italian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 26: Italian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Strategic Corporate Development
Select Key Players
B.Market Analytics
Table 27: The UK Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 28: The UK Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
4e. SPAIN
Market Analysis
Table 29: Spanish Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 30: Spanish Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
4f. RUSSIA
Market Analysis
Table 31: Russian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 32: Russian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Key Players
B.Market Analytics
Table 33: Rest of Europe Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 34: Rest of Europe Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
Market Analysis
Table 35: Asia-Pacific Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 36: Asia-Pacific Historic Review for Ion Channel Modulators by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 37: Asia-Pacific 12-Year Perspective for Ion Channel Modulators by Geographic Region
Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2018 (includes corresponding Graph/Chart)
5a. CHINA
Market Analysis
Table 38: Chinese Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 39: Chinese Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
5b. INDIA
Market Analysis
Table 40: Indian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 41: Indian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
Market Analysis
Table 42: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 43: Rest of Asia-Pacific Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. LATIN AMERICA
Market Analysis
Table 44: Latin American Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 45: Latin American Historic Review for Ion Channel Modulators with Annual Sales in US$ Million by Geographic Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 46: Latin American 12-Year Perspective for Ion Channel Modulators by Geographic Region
Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2007, 2015 & 2018 (includes corresponding Graph/Chart)
6a. BRAZIL
Market Analysis
Table 47: Brazilian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 48: Brazilian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
6b. REST OF LATIN AMERICA
Market Analysis
Table 49: Rest of Latin America Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 50: Rest of Latin America Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

7. REST OF WORLD
Market Analysis
Table 51: Rest of World Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
Table 52: Rest of World Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 47 (including Divisions/Subsidiaries - 50)

The United States (20)
Canada (1)
Japan (2)
Europe (26)
- France (2)
- Germany (6)
- The United Kingdom (6)
- Italy (2)
- Rest of Europe (10)
Asia-Pacific (Excluding Japan) (1)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S